07 Nov 2019 - South32 (ASX:S32) have entered into a binding conditional agreement for the sale of their 91.84 per cent shareholding in South32 SA Coal Holdings Proprietary.
06 Nov 2019 - Following a steady decline over the afternoon the S&P/ASX200 closed 0.6 per cent lower. Macquarie downgraded Blackmores (ASX:BKL) as an Underperform and reduces its 12-month price target to $58. Corporate Travel Management (ASX:CTD) confirmed its expectation for a 10 to 16.5% increase in EBITDA YoY.
06 Nov 2019 - The Australian share market opened lower despite positive leads from Wall Street and is now tracking flat at noon. Pendal Group (ASX:PDL) has topped the ASX best performers list despite a 23.5% decrease in NPAT compared to the prior corresponding period and a broker downgrade from Morgan Stanley.
06 Nov 2019 - Immutep Limited (ASX:IMM) CEO, Marc Voigt provides an update on the company's clinical trial data for its Phase 1 trial in melanoma, TACTI-mel, where patients are responding positively to the combination therapy of efti and Keytruda.
06 Nov 2019 - State Gas Limited (ASX:GAS) Executive Chairman, Richard Cottee provides an update on the company's key Reid’s Dome PL 231 gas project, drill program and timeline to production.
06 Nov 2019 - James Hardie Industries (ASX:JHX) has appointed Dr Moe Nozari as an independent non-executive director effective 6 November 2019.
06 Nov 2019 - Bubs Australia (ASX:BUB) has inked a strategic agreement with Alibaba Centralised Import Procurement to capitalise on the growth of China’s goat dairy market.
06 Nov 2019 - A US subsidiary of building and investment company Brickworks (ASX:BKW) has penned a binding agreement to acquire the assets of Redland Brick for approximately $70 million.
06 Nov 2019 - Medibank Private (ASX:MPL) has downgraded its FY20 outlook.
06 Nov 2019 - Following strong leads from US markets, the S&P/ASX200 is poised to edge higher at the open. The United States comes under intense criticism as it notifies the United Nations of its intention to withdraw from the Paris Agreement. The Oneview Healthcare (ASX:ONE) board is repositioning the roles of its three independent directors.
